DBCO-PEG4-NHS ester
CAS No. 1427004-19-0
DBCO-PEG4-NHS ester( —— )
Catalog No. M23584 CAS No. 1427004-19-0
DBCO-PEG4-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 132 | In Stock |
|
| 10MG | 222 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 536 | In Stock |
|
| 100MG | 777 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDBCO-PEG4-NHS ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionDBCO-PEG4-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionDBCO-PEG4-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1427004-19-0
-
Formula Weight649.69
-
Molecular FormulaC34H39N3O10
-
Purity>98% (HPLC)
-
SolubilityDMSO:79 mg/mL?(121.59 mM;?Need ultrasonic)
-
SMILESO=C(CCC(N(C1)c(cccc2)c2C#Cc2c1cccc2)=O)NCCOCCOCCOCCOCCC(ON(C(CC1)=O)C1=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Gefitinib-based PROT...
Gefitinib-based PROTAC 3 is a VHL-recruiting PROTAC that induces the degradation of EGFR and EGFR mutants with DC50 of 11.7 nM and 22.3 nM for HCC827 cell (Exon 19 del) and H3255 cell (L858R).
-
NH2-C2-NH-Boc
NH2-C2-NH-Boc (PROTAC Linker 22) is a alkyl chain-based PROTAC linker can be used in the synthesis of PROTACs. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
TL13-112
TL13-112 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of LDK378 and the cereblon ligand pomalidomide.
Cart
sales@molnova.com